|
FAM107B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66149999994525E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19429999999132E-05 |
| Normal-vs-Stage2 |
8.70640004535517E-09 |
| Normal-vs-Stage3 |
3.46049999999654E-06 |
| Normal-vs-Stage4 |
1.779260E-04 |
| Stage1-vs-Stage2 |
1.153540E-04 |
| Stage1-vs-Stage3 |
4.096000E-01 |
| Stage1-vs-Stage4 |
7.261800E-01 |
| Stage2-vs-Stage3 |
4.255500E-03 |
| Stage2-vs-Stage4 |
6.326100E-02 |
| Stage3-vs-Stage4 |
8.873600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57547999999341E-05 |
| Normal-vs-AfricanAmerican |
1.97469999999589E-05 |
| Normal-vs-Asian |
9.602500E-03 |
| Caucasian-vs-AfricanAmerican |
5.432000E-01 |
| Caucasian-vs-Asian |
5.491200E-01 |
| AfricanAmerican-vs-Asian |
3.512000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03789999999593E-05 |
| Normal-vs-Female |
2.26800000002747E-06 |
| Male-vs-Female |
5.152800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.982620E-04 |
| Normal-vs-Age(41-60Yrs) |
2.53399999983195E-07 |
| Normal-vs-Age(61-80Yrs) |
1.58829999996613E-06 |
| Normal-vs-Age(81-100Yrs) |
4.827400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.315600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.231800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.065400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.619400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.963700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.004000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.157200E-01 |
| Classical-VS-Follicular |
9.9031893796564E-14 |
| Classical-VS-Other |
2.053800E-01 |
| Classical-VS-Normal |
9.96920000000401E-05 |
| Tall-VS-Follicular |
4.317500E-03 |
| Tall-VS-Other |
2.531200E-01 |
| Tall-VS-Normal |
6.03449999999617E-05 |
| Follicular-VS-Other |
5.812200E-01 |
| Follicular-VS-Normal |
8.75860051152699E-10 |
| Other-VS-Normal |
9.96970000000097E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.4609999945483E-08 |
| Normal-vs-N1 |
9.52300000000017E-05 |
| N0-vs-N1 |
2.066600E-01 |
|
|
